Latest News

Pursuant to its U.S. Patent Application No. 17/204,106   NEW YORK, NY – (NewMediaWire) – November 1, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or ...

§  Interim Clinical Trial Data from Phase 2 expected in Q4/21 §  Nature Neuroscience and Cell Reports publications highlight 3CLpro (Mpro)’s complementary mechanisms of virus replication and ...

Cairo, Egypt – (NewMediaWire) – November 01, 2021 – MPS Infrastructure Inc. (“MPS) announced it has entered into a Consortium Agreement (the “Agreement”) with the ...

Presidential Advisory Highlights: Since the onset of the COVID-19 pandemic, scientific research was and continues to be significantly impacted on multiple levels, beginning with ...